资讯
Safdarjung Hospital has achieved a new milestone in its robotic surgery program with the successful conduct of a complex ...
Cold' tumors are resistant to common immunotherapies. Researchers have uncovered a master regulator that can be manipulated to prevent tumor growth in mice.
2 天
News-Medical.Net on MSNSerum hsa_circ_101555 as a promising biomarker for hepatocellular carcinomaHepatocellular carcinoma (HCC) represents the most prevalent malignancy in Egypt and globally. However, non-invasive ...
A protein identified nearly 40 years ago for its ability to stimulate the production of red blood cells plays a surprising, ...
Explore GISTs, rare GI tumors. Discover key details on genetic causes, diagnostic methods, and cutting-edge treatment ...
Glioblastoma multiforme is an aggressive brain tumor that mainly affects adults. Approximately 30,000 people in the U.S. are ...
The Risk Estimation of Tumor REcurrence After Transplant score accurately predicted hepatocellular carcinoma recurrence after liver transplantation.
UChicago Medicine is using a new technology to destroy liver tumors without radiation, chemotherapy or even cutting the skin.
Non-alcoholic fatty liver disease (NAFLD) is a hepatic metabolic syndrome resulting from lipid metabolic imbalance.
Clinical trials improve care and access to novel treatments for advanced gastrointestinal cancers, says Dr. Michael Pishvaian ...
As the trade war worsens, Beijing has banned the export of critical minerals used in the defense industry — but also for some ...
This can shrink some tumors or slow their growth. These drugs can be used in people with advanced liver cancer. Nivolumab can be used with the immunotherapy drug ipilimumab (Yervoy – see below), ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果